Abstract
Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Adolescent Psychiatry
Title: Albert Ellis Rational-Emotive Behavior Therapy
Volume: 1 Issue: 1
Author(s): Richard Rosner
Affiliation:
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Abstract: Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Export Options
About this article
Cite this article as:
Rosner Richard, Albert Ellis Rational-Emotive Behavior Therapy, Adolescent Psychiatry 2011; 1 (1) . https://dx.doi.org/10.2174/2210676611101010082
DOI https://dx.doi.org/10.2174/2210676611101010082 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Breath Analysis Using SIFT-MS to Assess Metabolic Status in Patients After Gastro-oesophageal Cancer Surgery- a Pilot Study
Current Analytical Chemistry Diabetic Patients with Psychiatric Illness
Current Diabetes Reviews Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Current Pharmaceutical Design Recent Progress in Medicinal Investigations on Trichosanthin and other Ribosome Inactivating Proteins from the Plant Genus Trichosanthes
Current Medicinal Chemistry Stem Cell Engineering for the Treatment of Severe Hemoglobinopathies
Current Molecular Medicine Clinical Trials in Children
Reviews on Recent Clinical Trials DTCM-Glutarimide Hinders Growth of Childhood Leukemia Cells but Fails to Improve the Efficacy of Commonly Used Chemotherapeutic Agents
Current Bioactive Compounds Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Ion-Responsive Drug Delivery Systems
Current Drug Targets Role of Sulfur Containing Amino Acids as an Adjuvant Therapy in the Prevention of Diabetes and its Associated Complications
Current Diabetes Reviews Drug Delivery Systems for Local Anesthetics
Recent Patents on Drug Delivery & Formulation Advances in Osteoclast Differentiation and Function
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases
Current Medicinal Chemistry Therapeutic Proteins for Treatment of Corneal Epithelial Defects
Current Medicinal Chemistry Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Recent Advances in Targeted Therapy for Glioma
Current Medicinal Chemistry A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Trimethylamine: Metabolic, Pharmacokinetic and Safety Aspects
Current Drug Metabolism Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials